Log in to save to my catalogue

Germline genetic variation in prostate susceptibility does not predict outcomes in the chemopreventi...

Germline genetic variation in prostate susceptibility does not predict outcomes in the chemopreventi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7237354

Germline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT

About this item

Full title

Germline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT

Publisher

London: Nature Publishing Group UK

Journal title

Prostate cancer and prostatic diseases, 2020-06, Vol.23 (2), p.333-342

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Background
The development of prostate cancer can be influenced by genetic and environmental factors. Numerous germline SNPs influence prostate cancer susceptibility. The functional pathways in which these SNPs increase prostate cancer susceptibility are unknown. Finasteride is currently not being used routinely as a chemoprevention agent but th...

Alternative Titles

Full title

Germline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7237354

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7237354

Other Identifiers

ISSN

1365-7852,1476-5608

E-ISSN

1476-5608

DOI

10.1038/s41391-019-0181-y

How to access this item